Title : Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease.

Pub. Date : 2021 Jul 27

PMID : 34269797






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This report illustrates that continuous-infusion VWF concentrate administration with or without intravenous immunoglobulin rapidly achieves target ristocetin cofactor activity and provides adequate hemostasis in aVWD associated with immunoglobulin G MGUS. Ristocetin von Willebrand factor Homo sapiens